GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Other Current Liabilities

NFL Biosciences (XPAR:ALNFL) Other Current Liabilities : €1.19 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Other Current Liabilities?

NFL Biosciences's other current liabilities for the quarter that ended in Dec. 2023 was €1.19 Mil.

NFL Biosciences's quarterly other current liabilities increased from Dec. 2022 (€0.07 Mil) to Jun. 2023 (€1.31 Mil) but then declined from Jun. 2023 (€1.31 Mil) to Dec. 2023 (€1.19 Mil).

NFL Biosciences's annual other current liabilities declined from Dec. 2021 (€0.13 Mil) to Dec. 2022 (€0.07 Mil) but then increased from Dec. 2022 (€0.07 Mil) to Dec. 2023 (€1.19 Mil).


NFL Biosciences Other Current Liabilities Historical Data

The historical data trend for NFL Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Other Current Liabilities Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial - - - - -

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial - - - - -

NFL Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


NFL Biosciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences (XPAR:ALNFL) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines